{"id":"NCT01336205","sponsor":"AstraZeneca","briefTitle":"Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation","officialTitle":"An Open-Label 52-week Study to Assess the Long-Term Safety of NKTR-118 in Opioid-Induced Constipation (OIC) in Patients With Non-Cancer-Related Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04","primaryCompletion":"2012-12","completion":"2012-12","firstPosted":"2011-04-15","resultsPosted":"2014-10-20","lastUpdate":"2014-10-20"},"enrollment":844,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Opioid-Induced Constipation (OIC)"],"interventions":[{"type":"DRUG","name":"NKTR-118","otherNames":[]},{"type":"DRUG","name":"Usual care","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the long-term safety and tolerability of NKTR-118 treatment of opioid-induced constipation (OIC) in patients with non-cancer-related pain.","primaryOutcome":{"measure":"Incidence of Patients Experiencing at Least One Adverse Event (AE)","timeFrame":"Baseline (Week 0) to end of the follow-up period","effectByArm":[{"arm":"NKTR-118 25 mg","deltaMin":437,"sd":null},{"arm":"Usual Care","deltaMin":195,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":169,"countries":["United States"]},"refs":{"pmids":["25112584"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=1390&filename=Clinical_Study_Report_Synopsis_D3820C00008.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":51,"n":534},"commonTop":["ABDOMINAL PAIN","DIARRHOEA","BACK PAIN","NAUSEA","HEADACHE"]}}